Total Funding
50
19
Total FundingSeries A raised
Growth Score
-7 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
95260
Apex Labs is a socially focused pharmaceutical company.
- Greg Rutherford: Chief Commercial Officer (CCO)
- Mark Johnston: Chief Medical OfficerPast Role: True North Clinical Research, Medical Director, Founder & CEO
About the Company
APEX’s clinical development program is focused on Veterans – a population disproportionately affected by mental health conditions. The Company’s lead clinical candidate is a low-dose synthetic psilocybin product for the treatment of Post-Traumatic Stress Disorder (PTSD) and treatment-resistant depression.
